PharmaRoth Labs, Inc.

ROTH · OTC
Analyze with AI
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Operating Activities
Net Income-$92-$233-$370-$291
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$67$24$105-$70
Other Non-Cash$7$123$234$146
Operating Cash Flow-$18-$86-$31-$215
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$18$86$6$220
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$20$0
Financing Cash Flow$18$86$26$220
Forex Effect$0$0$0$0
Net Chg. in Cash$0$0$0$0
Supplemental Information
Beg. Cash$1$1$6$1
End Cash$1$1$1$6
Free Cash Flow-$18$0$0$0